1. Home
  2. EYPT vs DFIN Comparison

EYPT vs DFIN Comparison

Compare EYPT & DFIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo EyePoint Pharmaceuticals Inc.

EYPT

EyePoint Pharmaceuticals Inc.

HOLD

Current Price

$18.26

Market Cap

1.5B

Sector

Industrials

ML Signal

HOLD

Logo Donnelley Financial Solutions Inc.

DFIN

Donnelley Financial Solutions Inc.

HOLD

Current Price

$46.31

Market Cap

1.2B

ML Signal

HOLD

Company Overview

Basic Information
Metric
EYPT
DFIN
Founded
1987
1983
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Laboratory Analytical Instruments
Other Consumer Services
Sector
Industrials
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
1.2B
IPO Year
2005
N/A

Fundamental Metrics

Financial Performance
Metric
EYPT
DFIN
Price
$18.26
$46.31
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
2
Target Price
$29.60
$63.50
AVG Volume (30 Days)
1.3M
293.1K
Earning Date
11-05-2025
10-29-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
1.12
Revenue
$42,339,000.00
$750,800,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$4.20
P/E Ratio
N/A
$41.32
Revenue Growth
N/A
N/A
52 Week Low
$3.91
$37.80
52 Week High
$19.11
$69.93

Technical Indicators

Market Signals
Indicator
EYPT
DFIN
Relative Strength Index (RSI) 66.55 48.10
Support Level $16.52 $45.72
Resistance Level $19.00 $47.19
Average True Range (ATR) 1.04 1.26
MACD 0.10 0.12
Stochastic Oscillator 74.24 60.88

Price Performance

Historical Comparison
EYPT
DFIN

About EYPT EyePoint Pharmaceuticals Inc.

EyePoint Pharmaceuticals Inc is a pharmaceutical company. It is engaged in developing and commercializing ophthalmic products for the treatment of eye diseases. The company has developed FDA-approved sustained-release treatments in ophthalmology. Its pre-clinical development program is focused on using its core Durasert E and Verisome technology platforms to deliver drugs to treat wet age-related macular degeneration, glaucoma, osteoarthritis, and other diseases. Geographically, the firm has operational footprints in the U.S., China, and the UK. It generates a majority of its revenue from the U.S.

About DFIN Donnelley Financial Solutions Inc.

Donnelley Financial Solutions Inc is a risk and compliance solutions company. The company provides regulatory filing and deal solutions via its software-as-a-service, technology-enabled services, and print and distribution solutions to public and private companies, mutual funds, and other regulated investment firms. The company operates in four segments: Capital Markets - Software Solutions, Capital Markets - Compliance and Communications Management, Investment Companies - Software Solutions and Investment Companies - Compliance and Communications Management. Its geographical segments are the United States( USA), Europe, Asia, Canada, and others, of which the USA accounts for the vast majority of its total revenue.

Share on Social Networks: